Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 51 | $13,526,727 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Mar 2025 19:33 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Director | 13 Mar 2025 | Sale | 36,291 | 7.19 | 260,932 | D |
12 Mar 2025 19:48 | ADPT | Adaptive Biotechnologies Corp | HERSHBERG ROBERT | Director | 12 Mar 2025 | Sale | 53,000 | 7.59 | 402,270 | D |
12 Mar 2025 19:47 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Director | 10 Mar 2025 | Sale | 10,000 | 7.05 | 70,500 | D |
06 Mar 2025 19:22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | Chief People Officer | 05 Mar 2025 | Sale | 7,085 | 6.98 | 49,453 | D |
06 Mar 2025 19:22 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | Chief People Officer | 05 Mar 2025 | Sale | 13,790 | 6.99 | 96,392 | D |
06 Mar 2025 19:22 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | 05 Mar 2025 | Sale | 26,023 | 6.98 | 181,641 | D |
06 Mar 2025 19:21 | ADPT | Adaptive Biotechnologies Corp | BENZENO SHARON | Chief Commercial Ofc Imm Med | 05 Mar 2025 | Sale | 41,600 | 6.98 | 290,368 | D |
06 Mar 2025 19:21 | ADPT | Adaptive Biotechnologies Corp | BENZENO SHARON | Chief Commercial Ofc Imm Med | 05 Mar 2025 | Sale | 3,065 | 6.99 | 21,424 | D |
06 Mar 2025 19:20 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Chief Financial Officer | 05 Mar 2025 | Sale | 3,103 | 6.97 | 21,628 | D |
06 Mar 2025 19:20 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Chief Financial Officer | 05 Mar 2025 | Sale | 253 | 6.98 | 1,766 | D |
06 Mar 2025 19:20 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Chief Financial Officer | 05 Mar 2025 | Sale | 6,964 | 6.99 | 48,678 | D |
06 Mar 2025 19:19 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | President and COO | 05 Mar 2025 | Sale | 40,044 | 6.98 | 279,507 | D |
06 Mar 2025 19:19 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | President and COO | 05 Mar 2025 | Sale | 19,461 | 6.99 | 136,032 | D |
06 Mar 2025 19:18 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | Chief Scientific Officer | 05 Mar 2025 | Sale | 40,603 | 6.98 | 283,409 | D |
06 Mar 2025 19:18 | ADPT | Adaptive Biotechnologies Corp | ROBINS HARLAN S | Chief Scientific Officer | 05 Mar 2025 | Sale | 56,053 | 6.99 | 391,810 | D |
06 Mar 2025 19:17 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 05 Mar 2025 | Sale | 81,206 | 6.98 | 566,818 | D |
06 Mar 2025 19:17 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 05 Mar 2025 | Sale | 36,145 | 6.99 | 252,654 | D |
06 Mar 2025 19:17 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 06 Mar 2025 | Sale | 102,218 | 7.64 | 780,946 | D |
06 Mar 2025 19:14 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Director | 06 Mar 2025 | Sale | 15,664 | 7.94 | 124,372 | D |
21 Feb 2025 19:28 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 19 Feb 2025 | Sale | 186,080 | 8.46 | 1,574,237 | D |
21 Feb 2025 19:28 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 20 Feb 2025 | Sale | 99,107 | 8.44 | 836,463 | D |
18 Feb 2025 20:21 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 13 Feb 2025 | Sale | 100,287 | 8.44 | 846,422 | D |
18 Feb 2025 20:21 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 14 Feb 2025 | Sale | 158,921 | 8.46 | 1,344,472 | D |
18 Feb 2025 20:21 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 18 Feb 2025 | Sale | 211,160 | 8.5 | 1,794,860 | D |
19 Nov 2024 18:45 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Chief Financial Officer | 18 Nov 2024 | Sale | 248 | 4.98 | 1,235 | D |
23 Aug 2024 16:27 | ADPT | Adaptive Biotechnologies Corp | TAYLOR STACY L | SVP and General Counsel | 22 Aug 2024 | Sale | 26,922 | 4.4974 | 121,079 | D |
06 Mar 2024 19:43 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Officer | 05 Mar 2024 | Sale | 7,727 | 3.43 | 26,504 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | TAYLOR STACY L | SVP and General Counsel | 05 Mar 2024 | Sale | 6,609 | 3.44 | 22,735 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | TAYLOR STACY L | SVP and General Counsel | 05 Mar 2024 | Sale | 6,772 | 3.43 | 23,228 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | Chief People Officer | 05 Mar 2024 | Sale | 1,813 | 3.44 | 6,237 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | LO FRANCIS | Chief People Officer | 05 Mar 2024 | Sale | 12,887 | 3.43 | 44,202 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | BENZENO SHARON | Chief Commercial Ofc Imm Med | 05 Mar 2024 | Sale | 18,644 | 3.44 | 64,135 | D |
06 Mar 2024 19:42 | ADPT | Adaptive Biotechnologies Corp | BENZENO SHARON | Chief Commercial Ofc Imm Med | 05 Mar 2024 | Sale | 10,746 | 3.43 | 36,859 | D |
06 Mar 2024 19:41 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | President | 05 Mar 2024 | Sale | 13,490 | 3.56 | 48,024 | D |
06 Mar 2024 19:41 | ADPT | Adaptive Biotechnologies Corp | RUBINSTEIN JULIE | President | 05 Mar 2024 | Sale | 25,580 | 3.43 | 87,739 | D |
06 Mar 2024 19:40 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 05 Mar 2024 | Sale | 15,456 | 3.44 | 53,169 | D |
06 Mar 2024 19:40 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 05 Mar 2024 | Sale | 42,794 | 3.43 | 146,783 | D |
06 Mar 2024 19:40 | ADPT | Adaptive Biotechnologies Corp | ROBINS CHAD M | CEO and Chairman | 05 Mar 2024 | Sale | 5,879 | 3.44 | 20,224 | D |
06 Mar 2024 19:39 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | 05 Mar 2024 | Sale | 6,975 | 3.44 | 23,994 | D |
06 Mar 2024 19:39 | ADPT | Adaptive Biotechnologies Corp | BOBULSKY SUSAN | Chief Commercial Officer, MRD | 05 Mar 2024 | Sale | 6,016 | 3.43 | 20,635 | D |
20 Nov 2023 17:30 | ADPT | Adaptive Biotechnologies Corp | PISKEL KYLE | Principal Accounting Officer | 16 Nov 2023 | Sale | 259 | 4.13 | 1,070 | D |
08 Aug 2023 16:53 | ADPT | Adaptive Biotechnologies Corp | SOOD NITIN | Chief Commercial Officer, MRD | 08 Aug 2023 | Sale | 10,550 | 6.54 | 68,997 | D |
08 Aug 2023 16:53 | ADPT | Adaptive Biotechnologies Corp | SOOD NITIN | Chief Commercial Officer, MRD | 07 Aug 2023 | Sale | 5,652 | 6.78 | 38,321 | D |
21 Jun 2023 17:32 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 20 Jun 2023 | Sale | 64,961 | 8.14 | 528,783 | D |
21 Jun 2023 17:32 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 20 Jun 2023 | Sale | 70,000 | 8.14 | 569,800 | D |
20 Jun 2023 17:41 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 15 Jun 2023 | Sale | 14,328 | 8.53 | 122,218 | D |
20 Jun 2023 17:41 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 15 Jun 2023 | Sale | 55,672 | 8.53 | 474,882 | D |
06 Jun 2023 16:23 | ADPT | Adaptive Biotechnologies Corp | PETERSON TYCHO | Chief Financial Officer | 02 Jun 2023 | Sale | 38,000 | 7.16 | 272,080 | D |
12 Apr 2023 18:04 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | Chief Operating Officer | 11 Apr 2023 | Sale | 2,308 | 8.63 | 19,918 | D |
12 Apr 2023 18:04 | ADPT | Adaptive Biotechnologies Corp | ADAMS R MARK | Chief Operating Officer | 10 Apr 2023 | Sale | 817 | 8.5 | 6,944 | D |
29 Mar 2023 17:01 | ADPT | Adaptive Biotechnologies Corp | GRIFFIN MICHELLE RENEE | Director | 27 Mar 2023 | Sale | 2,341 | 8.4913 | 19,878 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)